Pol DSR (40+30) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Zeal Laboratories Pvt Ltd.. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Pantoprazole Sodium Sesquihydrate, Domperidone (SR). This drug comes in the form of Tablet. The general packing available for this medicine consists of 10 Tablet and is priced at Rs 80 (arround $1.12 US Dollar)
The main active ingredients or salts in Pol DSR (40+30) are :
Pantoprazole Sodium Sesquihydrate-40 mg
Domperidone (SR)-30 mg
Pantoprazole Sodium Sesquihydrate Indication (Prescribed for or used as): Duodenal ulcer. Gastric ulcer. Reflux oesophagitis. Prophylaxis of NSAID associated peptic ulcer. Zollinger-ellison syndrome and other hypersecretory states.
For more details on Pantoprazole Sodium Sesquihydrate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Pantoprazole Sodium Sesquihydrate..
Domperidone (SR) Indication (Prescribed for or used as):
For more details on Domperidone (SR), its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Domperidone (SR)..
Pol DSR (40+30) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 90 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Pol DSR (40+30), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Pantoprazole Sodium Sesquihydrate-40 mg Domperidone (SR)-30 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.